{"pmid":32327295,"title":"COVID-19 or Pulmonary Contusion? A Diagnostic Dilemma.","text":["COVID-19 or Pulmonary Contusion? A Diagnostic Dilemma.","Acad Radiol","Rouhezamin, Mohammad Reza","Paydar, Shahram","Haseli, Sara","32327295"],"journal":"Acad Radiol","authors":["Rouhezamin, Mohammad Reza","Paydar, Shahram","Haseli, Sara"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327295","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.acra.2020.04.008","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664996914773360640,"score":8.518259,"similar":[{"pmid":32238427,"title":"Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic.","text":["Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic.","J Nucl Med","Zuckier, Lionel S","Moadel, Renee M","Haramati, Linda B","Freeman, Leonard","32238427"],"journal":"J Nucl Med","authors":["Zuckier, Lionel S","Moadel, Renee M","Haramati, Linda B","Freeman, Leonard"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238427","week":"202014|Mar 30 - Apr 05","doi":"10.2967/jnumed.120.245571","keywords":["covid-19","drug safety","other","respiratory","aerosal","lung scintigraphy","pulmonary embolism","ventilation"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664638354198626305,"score":66.84003},{"pmid":32147378,"pmcid":"PMC7127327","title":"COVID-19 and Blood Safety: Help with a Dilemma.","text":["COVID-19 and Blood Safety: Help with a Dilemma.","Transfus Med Rev","Dodd, Roger Y","Stramer, Susan L","32147378"],"journal":"Transfus Med Rev","authors":["Dodd, Roger Y","Stramer, Susan L"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147378","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.tmrv.2020.02.004","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664640874886201344,"score":48.04862},{"pmid":32241833,"pmcid":"PMC7113798","title":"Will children reveal their secret? The coronavirus dilemma.","text":["Will children reveal their secret? The coronavirus dilemma.","Eur Respir J","Cristiani, Luca","Mancino, Enrica","Matera, Luigi","Nenna, Raffaella","Pierangeli, Alessandra","Scagnolari, Carolina","Midulla, Fabio","32241833"],"journal":"Eur Respir J","authors":["Cristiani, Luca","Mancino, Enrica","Matera, Luigi","Nenna, Raffaella","Pierangeli, Alessandra","Scagnolari, Carolina","Midulla, Fabio"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241833","week":"202014|Mar 30 - Apr 05","doi":"10.1183/13993003.00749-2020","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664638249421766656,"score":47.65923},{"pmid":32324103,"title":"Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography.","text":["Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography.","Radiology","Grillet, Franck","Behr, Julien","Calame, Paul","Aubry, Sebastien","Delabrousse, Eric","32324103"],"journal":"Radiology","authors":["Grillet, Franck","Behr, Julien","Calame, Paul","Aubry, Sebastien","Delabrousse, Eric"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324103","week":"202017|Apr 20 - Apr 26","doi":"10.1148/radiol.2020201544","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664895932717596672,"score":46.859177},{"pmid":32241801,"title":"Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.","text":["Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.","Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention in the past few weeks with suggestions that this category of drugs may have potential in the management of coronavirus (SARS-CoV2) associated disease called COVID-19 [2, 3].","J Rheumatol","Scuccimarri, Rosie","Sutton, Evelyn","Fitzcharles, Mary-Ann","32241801"],"abstract":["Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention in the past few weeks with suggestions that this category of drugs may have potential in the management of coronavirus (SARS-CoV2) associated disease called COVID-19 [2, 3]."],"journal":"J Rheumatol","authors":["Scuccimarri, Rosie","Sutton, Evelyn","Fitzcharles, Mary-Ann"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241801","week":"202014|Mar 30 - Apr 05","doi":"10.3899/jrheum.200369","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine","Chloroquine"],"_version_":1664638249351512064,"score":43.07147}]}